Atea Pharmaceuticals Stock (NASDAQ:AVIR), Quotes and News Summary

Q: What sector and industry does Atea Pharmaceuticals (AVIR) operate in?

Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Atea Pharmaceuticals Stock (NASDAQ: AVIR) stock price, news, charts, stock research, profile.

Open	$3.700
Close	$3.700
Volume / Avg.	267.759K / 419.673K
Day Range	3.680 - 3.755
52 Wk Range	2.765 - 5.190
Market Cap	$311.409M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	2.57%
Days to Cover	3.24

Recent News

Atea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy

Atea Pharmaceuticals Inc (NASDAQ: AVIR) reported initial data from the first 52 patients in the lead-in cohort of its Phase 2 combination eight-week study of bemnifosbuvir and ruzasvir (RZR) for

Vandana Singh

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Lisa Levin

Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

1.7

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About Atea Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, devel...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Atea Pharmaceuticals (AVIR) stock?

You can purchase shares of Atea Pharmaceuticals (NASDAQ: AVIR) through any online brokerage.

View our list of the best stock brokerages.

Who are Atea Pharmaceuticals's (AVIR) competitors?

Other companies in Atea Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), SNDL (NASDAQ:SNDL) and Xeris Biopharma Holdings (NASDAQ:XERS).

What is the target price for Atea Pharmaceuticals (AVIR) stock?

The latest price target for Atea Pharmaceuticals (NASDAQ: AVIR) was reported by JP Morgan on Thursday, August 10, 2023. The analyst firm set a price target for 0.00 expecting AVIR to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Atea Pharmaceuticals (AVIR)?

The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $3.7 last updated April 18, 2024 at 4:00 PM EDT.

Does Atea Pharmaceuticals (AVIR) pay a dividend?

There are no upcoming dividends for Atea Pharmaceuticals.

When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?

Atea Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is Atea Pharmaceuticals (AVIR) going to split?

There is no upcoming split for Atea Pharmaceuticals.

What sector and industry does Atea Pharmaceuticals (AVIR) operate in?

Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-